These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 31221204)
21. Further Advances in Cancer Immunotherapy: Going Beyond Checkpoint Blockade. Wilkinson RW; Leishman AJ Front Immunol; 2018; 9():1082. PubMed ID: 29910800 [TBL] [Abstract][Full Text] [Related]
22. Managing immune dysregulation resulting from immune checkpoint inhibitors: impact of the ASCO guidelines and key take-homes for immunologists. Kim ST; Suarez-Almazor ME Expert Rev Clin Immunol; 2019 Mar; 15(3):211-213. PubMed ID: 30589372 [No Abstract] [Full Text] [Related]
23. Immune checkpoint blockade therapy for cancer: An overview of FDA-approved immune checkpoint inhibitors. Hargadon KM; Johnson CE; Williams CJ Int Immunopharmacol; 2018 Sep; 62():29-39. PubMed ID: 29990692 [TBL] [Abstract][Full Text] [Related]
24. [The "immune checkpoints", how does it work]. Granier C; Soumelis V; Mandavit M; Gibault L; Belazzoug R; de Guillebon E; Badoual C; Tartour E; Roussel H Ann Pathol; 2017 Feb; 37(1):18-28. PubMed ID: 28160999 [TBL] [Abstract][Full Text] [Related]
25. A tumor multicomponent targeting chemoimmune drug delivery system for reprograming the tumor microenvironment and personalized cancer therapy. Sau S; Tatiparti K; Alsaab HO; Kashaw SK; Iyer AK Drug Discov Today; 2018 Jul; 23(7):1344-1356. PubMed ID: 29551455 [TBL] [Abstract][Full Text] [Related]
26. Recent progress in therapeutic antibodies for cancer immunotherapy. Lee A; Sun S; Sandler A; Hoang T Curr Opin Chem Biol; 2018 Jun; 44():56-65. PubMed ID: 29885949 [TBL] [Abstract][Full Text] [Related]
27. Equibalancing immune-related adverse events and anticancer activity of immune checkpoint inhibitors. Seeruttun SR Thorac Cancer; 2019 Oct; 10(10):1855-1856. PubMed ID: 31456312 [No Abstract] [Full Text] [Related]
28. The immunopathogenesis of rheumatic immune adverse events from checkpoint inhibitors: prospects for targeted therapy. Calabrese LH; Calabrese C Curr Opin Rheumatol; 2020 Mar; 32(2):175-183. PubMed ID: 31922970 [TBL] [Abstract][Full Text] [Related]